Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation

A preliminary fMRI study

Tim Outhred, Pritha Das, Carol Dobson-Stone, Kim L Felmingham, Richard A Bryant, Pradeep J. Nathan, Gin S Malhi, Andrew H Kemp

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background The short ('S') allele of the serotonin transporter (5-HTT)-linked polymorphic region (5-HTTLPR) is associated with increased negative emotion processing bias, and this polymorphism moderates acute effects of selective serotonin reuptake inhibitor (SSRI) treatment. In this preliminary study, we explore the moderating effect of 5-HTTLPR on the impact of the SSRI, escitalopram during emotion regulation of negative emotional stimuli. Method Thirty-six healthy Caucasian, female participants underwent two fMRI scanning sessions following single dose escitalopram and placebo administration separated by a seven-day washout period according to a double-blind, randomized, placebo-controlled crossover design. Functional connectivity analysis was employed with a left (L) amygdala seed and a right interior frontal gyrus (R IFG) target. Results Changes in functional connectivity with emotion regulation and treatment were linearly related to 5-HTTLPR 'L' allele load such that negative R IFG-L amygdala connectivity was increased with an increasing number of 'L' alleles. Therefore, escitalopram may facilitate the effects of reappraisal by enhancing negative functional connectivity, a finding that is greatest in participants homozygous for the 'L' allele and least in those homozygous for the 'S' allele. Limitations Sub-samples of the homozygote 'S/S' and 'L/L' 5-HTTLPR groupings were small. However, the within-subjects nature of the experiment and observing changes at the individual subject level increases our confidence in the findings of the present study. Conclusions The present study elucidates a potential neural mechanism by which antidepressant treatment produces differential treatment outcomes dependent on the 5-HTTLPR polymorphism, providing new and important leads for models of antidepressant action.

Original languageEnglish
Pages (from-to)11-19
Number of pages9
JournalJournal of Affective Disorders
Volume196
DOIs
Publication statusPublished - 15 May 2016

Keywords

  • 5-HTTLPR
  • Antidepressant
  • Emotion
  • fMRI
  • Pharmacogenetics
  • Serotonin

Cite this

Outhred, Tim ; Das, Pritha ; Dobson-Stone, Carol ; Felmingham, Kim L ; Bryant, Richard A ; Nathan, Pradeep J. ; Malhi, Gin S ; Kemp, Andrew H. / Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation : A preliminary fMRI study. In: Journal of Affective Disorders. 2016 ; Vol. 196. pp. 11-19.
@article{e68725e60ae147dd9769c88560c473f3,
title = "Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study",
abstract = "Background The short ('S') allele of the serotonin transporter (5-HTT)-linked polymorphic region (5-HTTLPR) is associated with increased negative emotion processing bias, and this polymorphism moderates acute effects of selective serotonin reuptake inhibitor (SSRI) treatment. In this preliminary study, we explore the moderating effect of 5-HTTLPR on the impact of the SSRI, escitalopram during emotion regulation of negative emotional stimuli. Method Thirty-six healthy Caucasian, female participants underwent two fMRI scanning sessions following single dose escitalopram and placebo administration separated by a seven-day washout period according to a double-blind, randomized, placebo-controlled crossover design. Functional connectivity analysis was employed with a left (L) amygdala seed and a right interior frontal gyrus (R IFG) target. Results Changes in functional connectivity with emotion regulation and treatment were linearly related to 5-HTTLPR 'L' allele load such that negative R IFG-L amygdala connectivity was increased with an increasing number of 'L' alleles. Therefore, escitalopram may facilitate the effects of reappraisal by enhancing negative functional connectivity, a finding that is greatest in participants homozygous for the 'L' allele and least in those homozygous for the 'S' allele. Limitations Sub-samples of the homozygote 'S/S' and 'L/L' 5-HTTLPR groupings were small. However, the within-subjects nature of the experiment and observing changes at the individual subject level increases our confidence in the findings of the present study. Conclusions The present study elucidates a potential neural mechanism by which antidepressant treatment produces differential treatment outcomes dependent on the 5-HTTLPR polymorphism, providing new and important leads for models of antidepressant action.",
keywords = "5-HTTLPR, Antidepressant, Emotion, fMRI, Pharmacogenetics, Serotonin",
author = "Tim Outhred and Pritha Das and Carol Dobson-Stone and Felmingham, {Kim L} and Bryant, {Richard A} and Nathan, {Pradeep J.} and Malhi, {Gin S} and Kemp, {Andrew H}",
year = "2016",
month = "5",
day = "15",
doi = "10.1016/j.jad.2016.02.019",
language = "English",
volume = "196",
pages = "11--19",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation : A preliminary fMRI study. / Outhred, Tim; Das, Pritha; Dobson-Stone, Carol; Felmingham, Kim L; Bryant, Richard A; Nathan, Pradeep J.; Malhi, Gin S; Kemp, Andrew H.

In: Journal of Affective Disorders, Vol. 196, 15.05.2016, p. 11-19.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation

T2 - A preliminary fMRI study

AU - Outhred, Tim

AU - Das, Pritha

AU - Dobson-Stone, Carol

AU - Felmingham, Kim L

AU - Bryant, Richard A

AU - Nathan, Pradeep J.

AU - Malhi, Gin S

AU - Kemp, Andrew H

PY - 2016/5/15

Y1 - 2016/5/15

N2 - Background The short ('S') allele of the serotonin transporter (5-HTT)-linked polymorphic region (5-HTTLPR) is associated with increased negative emotion processing bias, and this polymorphism moderates acute effects of selective serotonin reuptake inhibitor (SSRI) treatment. In this preliminary study, we explore the moderating effect of 5-HTTLPR on the impact of the SSRI, escitalopram during emotion regulation of negative emotional stimuli. Method Thirty-six healthy Caucasian, female participants underwent two fMRI scanning sessions following single dose escitalopram and placebo administration separated by a seven-day washout period according to a double-blind, randomized, placebo-controlled crossover design. Functional connectivity analysis was employed with a left (L) amygdala seed and a right interior frontal gyrus (R IFG) target. Results Changes in functional connectivity with emotion regulation and treatment were linearly related to 5-HTTLPR 'L' allele load such that negative R IFG-L amygdala connectivity was increased with an increasing number of 'L' alleles. Therefore, escitalopram may facilitate the effects of reappraisal by enhancing negative functional connectivity, a finding that is greatest in participants homozygous for the 'L' allele and least in those homozygous for the 'S' allele. Limitations Sub-samples of the homozygote 'S/S' and 'L/L' 5-HTTLPR groupings were small. However, the within-subjects nature of the experiment and observing changes at the individual subject level increases our confidence in the findings of the present study. Conclusions The present study elucidates a potential neural mechanism by which antidepressant treatment produces differential treatment outcomes dependent on the 5-HTTLPR polymorphism, providing new and important leads for models of antidepressant action.

AB - Background The short ('S') allele of the serotonin transporter (5-HTT)-linked polymorphic region (5-HTTLPR) is associated with increased negative emotion processing bias, and this polymorphism moderates acute effects of selective serotonin reuptake inhibitor (SSRI) treatment. In this preliminary study, we explore the moderating effect of 5-HTTLPR on the impact of the SSRI, escitalopram during emotion regulation of negative emotional stimuli. Method Thirty-six healthy Caucasian, female participants underwent two fMRI scanning sessions following single dose escitalopram and placebo administration separated by a seven-day washout period according to a double-blind, randomized, placebo-controlled crossover design. Functional connectivity analysis was employed with a left (L) amygdala seed and a right interior frontal gyrus (R IFG) target. Results Changes in functional connectivity with emotion regulation and treatment were linearly related to 5-HTTLPR 'L' allele load such that negative R IFG-L amygdala connectivity was increased with an increasing number of 'L' alleles. Therefore, escitalopram may facilitate the effects of reappraisal by enhancing negative functional connectivity, a finding that is greatest in participants homozygous for the 'L' allele and least in those homozygous for the 'S' allele. Limitations Sub-samples of the homozygote 'S/S' and 'L/L' 5-HTTLPR groupings were small. However, the within-subjects nature of the experiment and observing changes at the individual subject level increases our confidence in the findings of the present study. Conclusions The present study elucidates a potential neural mechanism by which antidepressant treatment produces differential treatment outcomes dependent on the 5-HTTLPR polymorphism, providing new and important leads for models of antidepressant action.

KW - 5-HTTLPR

KW - Antidepressant

KW - Emotion

KW - fMRI

KW - Pharmacogenetics

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=84958775705&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2016.02.019

DO - 10.1016/j.jad.2016.02.019

M3 - Article

VL - 196

SP - 11

EP - 19

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -